These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6059055)

  • 1. Cephaloridine excretion in patients with normal and impaired renal function.
    Pryor JS; Joekes AM; Foord RD
    Postgrad Med J; 1967 Aug; 43():Suppl 43:82-5. PubMed ID: 6059055
    [No Abstract]   [Full Text] [Related]  

  • 2. The renal excretion of cephaloridine in man.
    Foley TH; Jones NF; Barraclough MA; Cranston WI; Hunt AP
    Postgrad Med J; 1967 Aug; 43():Suppl 43:85-7. PubMed ID: 6052336
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with cephaloridine in renal impairment.
    Bechtol LD
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):790-800. PubMed ID: 4629818
    [No Abstract]   [Full Text] [Related]  

  • 4. Excretion of cephaloridine and cephalothin in patients with renal impairment.
    Kunin CM; Atuk N
    N Engl J Med; 1966 Mar; 274(12):654-6. PubMed ID: 17926378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of posture on creatinine clearance and urinary protein excretion in patients with various renal diseases.
    Wan LL; Yano S; Hiromura K; Tsukada Y; Tomono S; Kawazu S
    Clin Nephrol; 1995 May; 43(5):312-7. PubMed ID: 7634546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionised and total serum magnesium in renal transplant patients.
    Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
    J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of urinary pH on the renal clearance of cephaloridine.
    Asscher AW; Johnson SE; Simon DA
    Postgrad Med J; 1970 Oct; ():Suppl:55-7. PubMed ID: 5488209
    [No Abstract]   [Full Text] [Related]  

  • 9. Creatinine clearance predicted from body cell mass is a good indicator of renal function.
    Donadio C; Lucchesi A; Tramonti G; Bianchi C
    Kidney Int Suppl; 1997 Dec; 63():S166-8. PubMed ID: 9407449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cephaloridine in the human organism during its intravenous administration].
    Dvorácek K; Modr Z; Grafnetterová J; Bláha V; Necásková A
    Cas Lek Cesk; 1969 Feb; 108(9):258-63. PubMed ID: 5779475
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatinine clearance: alternative approach to traditional 24-hour urine collection in normal individuals.
    Adebisi SA; Adekunle BA; Etu AK
    Afr J Med Med Sci; 2001; 30(1-2):27-30. PubMed ID: 14510145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute protein loading in the assessment of renal reserve.
    Loo CS; Zaki M; Sulaiman AB; Sukanya AB; Voon YC; Kua SL
    Med J Malaysia; 1994 Mar; 49(1):36-43. PubMed ID: 8057988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-hour urine collection for evaluating renal function correlates with 24-hour urine collection in pregnant patients.
    Evans W; Lensmeyer JP; Kirby RS; Malnory ME; Broekhuizen FF
    J Matern Fetal Med; 2000; 9(4):233-7. PubMed ID: 11048835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria.
    Xin G; Wang M; Jiao LL; Xu GB; Wang HY
    Clin Chim Acta; 2004 Dec; 350(1-2):35-9. PubMed ID: 15530457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cephaloridine in reduced kidney function].
    Neuhaus G; Willbrandt R; Fritz KW; Lange A; Volkening R
    Med Welt; 1971 Jul; 22(29):1209-12. PubMed ID: 5566157
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased D-glucaric acid excretion in children with renal disease.
    Németh I; Szeleczki T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):357-60. PubMed ID: 7409939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ; Ing TS; Soung LS; Daugirdas JT; Hano JE; Gandhi VC
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary prostaglandin-E2 in chronic renal disease.
    Blum M; Bauminger S; Algueti A; Kisch E; Ayalon D; Aviram A
    Clin Nephrol; 1981 Feb; 15(2):87-9. PubMed ID: 7214757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of Tamm-Horsfall glycoprotein in renal disease.
    Lynn KL; Marshall RD
    Clin Nephrol; 1984 Nov; 22(5):253-7. PubMed ID: 6518675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.